Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Archives of General Psychiatry
|
June 1, 1987
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome
S R Marder, T Van Putten, J Mintz, et al.
Psychiatry Research
|
February 1, 1989
Comparison of electromechanical measures and observer ratings of tardive dyskinesia
G Bartzokis, W C Wirshing, M A Hill, et al.
Archives of General Psychiatry
|
July 1, 1981
Schizophrenia. A follow-up study of the results of five forms of treatment
P R May, A H Tuma, W J Dixon, et al.
Archives of General Psychiatry
|
November 1, 1984
Costs and benefits of two doses of fluphenazine
S R Marder, T Van Putten, J Mintz, et al.
Comprehensive Psychiatry
|
March 1, 1981
Prognosis in schizophrenia: individual differences in psychological response to a test dose of antipsychotic drug and their relationship to blood and saliva levels and treatment outcome
P R May, T Van Putten, D J Jenden, et al.
Psychopharmacology
|
January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate
K K Midha, J W Hubbard, S R Marder, et al.
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
The Journal of Nervous and Mental Disease
|
March 1, 1976
Predicting individual responses to drug treatment in schizophrenia: a test dose model
P R May, T Van Putten, C Yale, et al.
Psychopharmacology Bulletin
|
January 1, 1986
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate
S R Marder, J W Hubbard, T Van Putten, et al.
Therapeutic Drug Monitoring
|
January 1, 1985
Therapeutic monitoring of chlorpromazine I: Pitfalls in plasma analysis
J W Hubbard, J K Cooper, E M Hawes, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Archives of General Psychiatry
|
June 1, 1987
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome
S R Marder, T Van Putten, J Mintz, et al.
Psychiatry Research
|
February 1, 1989
Comparison of electromechanical measures and observer ratings of tardive dyskinesia
G Bartzokis, W C Wirshing, M A Hill, et al.
Archives of General Psychiatry
|
July 1, 1981
Schizophrenia. A follow-up study of the results of five forms of treatment
P R May, A H Tuma, W J Dixon, et al.
Archives of General Psychiatry
|
November 1, 1984
Costs and benefits of two doses of fluphenazine
S R Marder, T Van Putten, J Mintz, et al.
Comprehensive Psychiatry
|
March 1, 1981
Prognosis in schizophrenia: individual differences in psychological response to a test dose of antipsychotic drug and their relationship to blood and saliva levels and treatment outcome
P R May, T Van Putten, D J Jenden, et al.
Psychopharmacology
|
January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate
K K Midha, J W Hubbard, S R Marder, et al.
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
The Journal of Nervous and Mental Disease
|
March 1, 1976
Predicting individual responses to drug treatment in schizophrenia: a test dose model
P R May, T Van Putten, C Yale, et al.
Psychopharmacology Bulletin
|
January 1, 1986
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate
S R Marder, J W Hubbard, T Van Putten, et al.
Therapeutic Drug Monitoring
|
January 1, 1985
Therapeutic monitoring of chlorpromazine I: Pitfalls in plasma analysis
J W Hubbard, J K Cooper, E M Hawes, et al.
Page
of 8